Deutsche Bank Flags Stabilization in European MedTech and Life Sciences After Q2 Reports
Deutsche Bank says the Q2 reporting season for European MedTech and Life Sciences produced more earnings beats than misses, though results were partly supported by non-operational items such as tariff refunds. Consensus revisions for 2027 remain negative but the pace of cuts has slowed, prompting a small sector re-rating; further valuation improvem…